Department of Obstetrics and Gynecology, Maternal and Child Health Research Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Am J Perinatol. 2021 Dec;38(14):1500-1504. doi: 10.1055/s-0040-1713818. Epub 2020 Jun 28.
Studies demonstrate shorter time to delivery with concurrent use of misoprostol and cervical Foley catheter. However, concurrent placement may not be feasible. If misoprostol is used to start an induction, little is known regarding the benefit of sequentially using Foley catheter. We examine obstetrical outcomes in women with Foley catheter placed after misoprostol compared with those only requiring misoprostol.
Retrospective cohort study of singleton pregnancies, intact membranes, and an unfavorable cervix (Bishop score of ≤6 and dilation ≤2 cm) undergoing term induction May 2013 to June 2015. We compared obstetrical outcomes between women receiving misoprostol alone versus those that had a Foley catheter placed after misoprostol. Outcomes are mode of delivery, time to delivery, chorioamnionitis, admission to neonatal intensive care unit, and maternal morbidity. Chi-square and Fisher's exact tests were used for categorical variables, Mann-Whitney -tests compared continuous variables.
Among 364 women, 281 began induction with misoprostol alone. A total of 135 (48%) subsequently had a Foley catheter placed. Characteristics were similar between the groups, although nulliparity and cervical dilation <1 cm at start of induction were more likely to have subsequent Foley catheter. Women with Foley catheter placement after misoprostol had a longer median time to delivery (15 vs. 11 hours, < 0.001), twofold higher rate of cesarean (42 vs. 26%, odds ratio: 2.1, 95% confidence interval: 1.26-3.44, = 0.004), and increased risk of neonatal intensive care unit (NICU) admission (21 vs. 11%, = 0.024). There was a nonsignificant increased risk of chorioamnionitis (12 vs. 7%, = 0.1) and maternal morbidity (15 vs. 8%, = 0.08) in the misoprostol followed by Foley catheter group.
In women receiving misoprostol for induction, nulliparas and those with dilation <1 cm are more likely to have subsequent Foley catheter placement. Sequential use of cervical Foley catheter after misoprostol is associated with longer labor, higher cesarean rate, and increased NICU admission. Requirement of Foley catheter after misoprostol confers higher risk and may guide counseling.
· Little is known regarding efficacy of misoprostol followed by cervical Foley catheter.. · Nulliparas and dilation <1 cm increases need for Foley after misoprostol.. · Complications were more common in women requiring Foley after misoprostol..
研究表明,米索前列醇与宫颈 Foley 导管同时使用可缩短分娩时间。然而,同时放置可能不可行。如果米索前列醇用于引产,那么对于 Foley 导管序贯使用的益处知之甚少。我们检查了 Foley 导管在米索前列醇之后放置的妇女与仅需要米索前列醇的妇女的产科结局。
对 2013 年 5 月至 2015 年 6 月期间接受足月引产的单胎妊娠、胎膜完整和宫颈不利(Bishop 评分≤6 且扩张≤2cm)的妇女进行回顾性队列研究。我们比较了单独使用米索前列醇和米索前列醇后放置 Foley 导管的妇女的产科结局。结局为分娩方式、分娩时间、绒毛膜羊膜炎、新生儿重症监护病房入院和产妇发病率。分类变量采用卡方和 Fisher 确切检验,连续变量采用 Mann-Whitney U 检验。
在 364 名妇女中,有 281 名妇女单独开始使用米索前列醇引产。共有 135 名(48%)妇女随后放置了 Foley 导管。两组的特征相似,但初产妇和诱导开始时宫颈扩张<1cm 更有可能随后放置 Foley 导管。米索前列醇后放置 Foley 导管的妇女中位分娩时间更长(15 与 11 小时, < 0.001),剖宫产率高两倍(42 与 26%,比值比:2.1,95%置信区间:1.26-3.44, = 0.004),新生儿重症监护病房(NICU)入院风险增加(21 与 11%, = 0.024)。米索前列醇后 Foley 导管组绒毛膜羊膜炎(12 与 7%, = 0.1)和产妇发病率(15 与 8%, = 0.08)的风险增加无统计学意义。
在接受米索前列醇引产的妇女中,初产妇和宫颈扩张<1cm 的妇女更有可能随后放置 Foley 导管。米索前列醇后序贯使用宫颈 Foley 导管与分娩时间延长、剖宫产率增加和 NICU 入院增加相关。米索前列醇后需要 Foley 导管会增加风险,并可能指导咨询。
· 关于米索前列醇后使用宫颈 Foley 导管的疗效知之甚少。· 初产妇和宫颈扩张<1cm 增加了米索前列醇后 Foley 导管的需求。· 米索前列醇后需要 Foley 导管的妇女并发症更常见。